Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 6
2002 5
2003 1
2004 2
2005 3
2006 2
2007 1
2008 1
2009 2
2010 3
2011 3
2013 1
2016 1
2018 1
2020 1
2022 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients.
Vassilakopoulos TP, Arapaki M, Diamantopoulos PT, Liaskas A, Panitsas F, Siakantaris MP, Dimou M, Kokoris SI, Sachanas S, Belia M, Chatzidimitriou C, Konstantinou EA, Asimakopoulos JV, Petevi K, Boutsikas G, Kanellopoulos A, Piperidou A, Lefaki ME, Georgopoulou A, Kopsaftopoulou A, Zerzi K, Drandakis I, Dimopoulou MN, Kyrtsonis MC, Tsaftaridis P, Plata E, Variamis E, Tsourouflis G, Kontopidou FN, Konstantopoulos K, Pangalis GA, Panayiotidis P, Angelopoulou MK. Vassilakopoulos TP, et al. Among authors: kontopidou fn. Cancers (Basel). 2024 Jan 5;16(2):238. doi: 10.3390/cancers16020238. Cancers (Basel). 2024. PMID: 38254729 Free PMC article.
Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.
Vassilakopoulos TP, Kravvariti E, Panitsas F, Angelopoulou MK, Liaskas A, Kontopidou FN, Yiakoumis X, Variami E, Dimopoulou MN, Siakantaris MP, Asimakopoulos JV, Arapaki M, Dimou M, Diamantopoulos P, Sachanas S, Chatzidimitriou C, Belia M, Konstantinou E, Boutsikas G, Petevi K, Kanellopoulos A, Kokoris S, Kyrtsonis MC, Viniou NA, Lakiotaki E, Tsourouflis G, Korkolopoulou P, Konstantopoulos K, Panayiotidis P, Pangalis GA. Vassilakopoulos TP, et al. Among authors: kontopidou fn. Blood Cancer J. 2022 Jul 5;12(7):102. doi: 10.1038/s41408-022-00674-w. Blood Cancer J. 2022. PMID: 35790712 Free PMC article. No abstract available.
Validation of the simplified International Prognostic Score3 in a Hellenic cohort of patients with advanced-stage Hodgkin-lymphoma.
Asimakopoulos JV, Angelopoulou MK, Arapaki MP, Kanellopoulos A, Dimou M, Giakoumis X, Konstantinou E, Belia M, Chatzidimitriou C, Sachanas S, Iliakis T, Kyrtsonis MC, Siakantaris MP, Viniou NA, Variamis E, Kontopidou FN, Pangalis GA, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP. Asimakopoulos JV, et al. Among authors: kontopidou fn. Br J Haematol. 2020 Sep;190(6):e335-e339. doi: 10.1111/bjh.16903. Epub 2020 Jun 30. Br J Haematol. 2020. PMID: 32602960 No abstract available.
Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.
Kalpadakis C, Pangalis GA, Sachanas S, Tsirkinidis P, Kontopidou FN, Moschogiannis M, Yiakoumis X, Koulieris E, Dimopoulou MN, Kokkoris SI, Kyrtsonis MC, Siakantaris MP, Tsourouflis G, Korkolopoulou P, Rontogianni D, Tsaftaridis P, Plata E, Papadaki HA, Panagiotidis P, Angelopoulou MK, Vassilakopoulos TP. Kalpadakis C, et al. Among authors: kontopidou fn. Blood. 2018 Aug 9;132(6):666-670. doi: 10.1182/blood-2018-02-833608. Epub 2018 Jun 18. Blood. 2018. PMID: 29914978 Free article. No abstract available.
Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.
Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Kontopidou FN, Yiakoumis X, Kokoris SI, Dimitriadou EM, Dimopoulou MN, Moschogiannis M, Korkolopoulou P, Kyrtsonis MC, Siakantaris MP, Papadaki T, Tsaftaridis P, Plata E, Papadaki HE, Vassilakopoulos TP. Kalpadakis C, et al. Among authors: kontopidou fn. Oncologist. 2013;18(2):190-7. doi: 10.1634/theoncologist.2012-0251. Epub 2013 Jan 23. Oncologist. 2013. PMID: 23345547 Free PMC article.
Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen.
Sachanas S, Pangalis GA, Vassilakopoulos TP, Korkolopoulou P, Kontopidou FN, Athanasoulia M, Yiakoumis X, Kalpadakis C, Georgiou G, Masouridis S, Moschogiannis M, Tsirkinidis P, Pappis V, Kokoris SI, Siakantaris MP, Panayiotidis P, Angelopoulou MK. Sachanas S, et al. Among authors: kontopidou fn. Leuk Lymphoma. 2011 Mar;52(3):387-93. doi: 10.3109/10428194.2010.534518. Epub 2010 Dec 6. Leuk Lymphoma. 2011. PMID: 21133713 Clinical Trial.
36 results